About Revenio Group Oyj

Company Description

Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. Revenio Group's ophthalmic diagnostic solutions include intraocular pressure measurement devices under the iCare brand, retinal imaging devices and perimeters. The main tools for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

The Revenio Group comprises Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S. R. L, CenterVue SpA, Revenio Research Oy, Revenio Australia Pty Ltd, Icare World Australia Pty Ltd, CT Operations International UK Ltd, Done Medical Oy and Oscare Medical Oy.

Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Served area



Γ„yritie 22, 1510 Vantaa – Finland

Shareholder information

Shares outstanding



Oct. 1, 2001

Stock exchange(s)

Nasdaq Helsinki



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.